Cantor Fitzgerald Maintains Overweight on Alkermes, Lowers Price Target to $43
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Charles Duncan maintains an Overweight rating on Alkermes (NASDAQ:ALKS) but lowers the price target from $48 to $43.
October 25, 2024 | 3:59 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cantor Fitzgerald's analyst Charles Duncan maintains an Overweight rating on Alkermes but reduces the price target from $48 to $43, indicating a slightly less optimistic outlook.
The Overweight rating suggests continued confidence in Alkermes, but the lowered price target indicates a tempered outlook. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100